PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment by JA Roman Ivorra, M de la Rubia Navarro, I Canovas Olmos, R Gonzalez Mazario, L Gonzalez Puig, E Grau Garcia, I Martinez Cordellat, C Najera Herranz, R Negueroles Albuixech, E Vicens Bernabeu, C Riesco Barcena, S Leal Rodríguez, C Pávez Perales, AV Huaylla Quispe, P Muñoz Martínez, L Mas Sánchez, J Oller Rodríguez, JR Ivorra Cortes, J Fragio Gil

PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients by JA Roman Ivorra, M de la Rubia Navarro, I Canovas Olmos, L Gonzalez Puig, E Grau Garcia, I Martinez Cordellat, R Negueroles Albuixech, JE Oller Rodriguez, E Vicens Bernabeu, C Riesco Barcena, S Leal Rodríguez, C Pávez Perales, AV Huaylla Quispe, P Muñoz Martínez, L Mas Sánchez, JR Ivorra Cortes, C Herranz Najera, OS Francisco Miguel, J Fragio Gil

PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus by JA Roman Ivorra, J Ivorra Cortes, I Canovas Olmos, JJ Fragio Gil, L Gonzalez Puig, E Grau Garcia, I Martinez Cordellat, C Najera Herranz, R Negueroles Albuixech, E Vicens Bernabeu, M de la Rubia, C Riesco Barcena, S Leal Rodríguez, ME Acosta de la Vega, C Pávez Perales, AV Huaylla Quispe, P Muñoz Martínez, L Mas Sánchez, F Ortiz-Sanjuán, J Oller Rodríguez